According to the latest report on November 30, the State Food and Drug Administration issued a notice saying that two cold medicines had been stopped from use, production and sale! There is also a batch of cold medicine, which is forbidden for children. Netizens said they would hurry home to find it.
Terphene pseudoephedrine tablets and Trojan pseudoephedrine capsules are discontinued and discontinued today
On November 30, the State Food and Drug Administration issued the announcement on stopping the production and sale of terphene pseudoephedrine tablets and Trojan pseudoephedrine capsules (No. 92, 2018).
According to the provisions of Article 42 of the drug administration law of the people's Republic of China and Article 40 of the regulations for the implementation of the drug administration law of the people's Republic of China, after the reevaluation organized by the State Drug Administration, it is believed that there are adverse effects of cardiotoxicity and the risk of use is greater than the benefit. Therefore, it is decided to stop the use of the drug from now on Production, sale and use of sachet in China, and revocation of relevant drug approval documents.
Applicable to headache, fever, sneeze, recall and destruction of listed products
According to the drug manual, each tablet contains 162.5mg of paracetamol, 15mg of pseudoephedrine hydrochloride, 15mg of terfenadine, which is suitable for headache, fever, sore limbs, stuffy nose, runny nose, tears, sneezing and other symptoms caused by cold.
Requirements of the State Food and Drug Administration: the manufacturer shall recall the marketed pseudoephedrine tablets and Trojan pseudoephedrine capsules, and the recall shall be completed before December 31, 2018, and the recalled products shall be destroyed under the supervision of the local drug supervision and administration department.
According to the information provided by the State Food and drug administration, these two products involve two pharmaceutical enterprises, namely: Lizhu pharmaceutical factory of Lizhu group and Ouyi Pharmaceutical Co., Ltd. of Shiyao group.
These cold related drugs are forbidden for children (teenagers)
In autumn and winter, colds often come by accident. In fact, some cold medicines are restricted.
Cold medicine containing codeine, forbidden under 18 years old
On September 6, the State Food and Drug Administration issued the notice on Revision of the manual of codeine containing cold medicine (No. 63, 2018), which proposed revision requirements for the manual, and the relevant content in the [contraindications] was revised to "prohibited for children under 18 years old".
These drugs include: Paracetamol dihydrocodeine tablets, compound codeine phosphate syrup, compound codeine phosphate oral solution, codeine phosphate syrup, etc., a total of 29 batches.
Shuanghuanglian injection, forbidden for children aged 4 and under
On June 11, the State Food and Drug Administration issued the notice on Revising the instruction manual of Shuanghuanglian injection (No. 31, 2018), adding warning words to the instruction manual of Shuanghuanglian injection (Shuanghuanglian injection, Shuanghuanglian for injection (freeze dry), Shuanghuanglian powder injection), and revising the items of adverse reactions, taboos and precautions.
The "taboo" item clearly indicates that children aged 4 and below are prohibited.
Chaihu Injection, forbidden for children
On May 29, the State Food and Drug Administration issued the announcement on Revising the instructions of Chaihu Injection (No. 26, 2018), adding warning words to the instructions of Chaihu Injection, and revising the [adverse reactions], [taboos], [precautions] and other items.
The amendment requires that "forbidden for children" should be listed under the taboo item, and the warning words "adverse reactions of this product include anaphylactic shock" should be added.
Pidomode preparation, forbidden for children under 3 years old
On March 9, the former State Food and Drug Administration issued the announcement on Amending the instructions of pidomode preparation (No. 30, 2018).
The indications for pidomode are limited to 'adjuvant treatment of chronic or recurrent respiratory and urinary tract infections'. 'and it is clear in the [contraindications] that' children under 3 years old are prohibited. '
Lysine for injection should be used cautiously under the age of 16 and forbidden for less than 3 months
On January 31, the former State Food and Drug Administration issued the announcement on Amending the instruction manual of lysine for injection (No. 11, 2018). [children's medication] is modified as: children under 16 years old should use it with caution, and infants under 3 months old should not use it.
Lysine for aspirin and lysine complex salt, non steroidal anti-inflammatory antipyretic analgesic drugs, with antipyretic, analgesic, anti-inflammatory effect, suitable for fever and light, moderate pain.
In addition, a summary of the restrictions and cautions of some drugs for children is as follows: